Table 1 Characteristics of study participants
Age, years median (IQR) | Female sex, number (%) | Faecal calprotectin, μg/g, median (IQR) | ESSDAI/DAS28-CRP(3), median (IQR) | |
|---|---|---|---|---|
Systemic sclerosis (n = 93) | 62 (51 to 70) | 77 (83) | 110 (42 to 210) | NA |
Primary Sjögren’s syndrome (n = 44) | 61 (55 to 68) | 43 (98) | 41 (<30 to 118) | 7 (1 to 10) |
Rheumatoid arthritis (n = 24) | 66 (55 to 69) | 20 (83) | 43 (<30 to 93) | 3.1 (2.1 to 3.9) |
Healthy controls (n = 21) | 56 (47 to 58) | 17 (81) | <30 (<30 to 56) | NA |